Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022
Circulating tumour DNA analysis can help identify the need for adjuvant therapy ...
Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022
UICC announces global coalition to increase access to essential cancer medicines...
Dr Cary Adams - Chief Executive Officer, UICC
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries ( Dr Cary Adams - Chief Executive Officer, UICC )
4 Jun 2022
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
4 Jun 2022
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL (  )
3 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
Diagnostic performance and survival outcome of SLNB procedure in breast cancer p...
Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India
Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre ( Dr Sanjit Kumar Agrawal - Tata Medical Center, Kolkata, India )
25 May 2022
COMy 2022: Multiple myeloma roundup
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
COMy 2022: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
24 May 2022
Youth Cancer Europe: Aiding Ukrainian refugees during the crisis
Katie Rizvi - Youth Cancer Europe, Cluj-Napoca, Romania
Youth Cancer Europe: Aiding Ukrainian refugees during the crisis ( Katie Rizvi - Youth Cancer Europe, Cluj-Napoca, Romania )
24 May 2022
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses...
Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma ( Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA )
19 May 2022
War in Ukraine: Impacts on the Slovakian cancer care system
Dr Darina Sedláková - Slovak League Against Cancer, Bratislava, Slovakia
War in Ukraine: Impacts on the Slovakian cancer care system ( Dr Darina Sedláková - Slovak League Against Cancer, Bratislava, Slovakia )
11 May 2022